References
- Circolare del Ministero della Salute. 2021. Raccomandazioni sulla vaccinazione anti SARS-CoV-2/COVID-19 in gravidanza e allattamento. Ministero della salute, n. 43293.
- Di Mascio, D., et al., 2021. Risk factors associated with adverse fetal outcomes in pregnancies affected by Coronavirus disease 2019 (COVID-19): a secondary analysis of the WAPM study on COVID-19. Journal of Perinatal Medicine, 49 (1), 111–115.
- Donati, S., et al., 2022. ItOSS-COVID-19 Working Group. SARS-CoV-2 infection among hospitalised pregnant women and impact of different viral strains on COVID-19 severity in Italy: a national prospective population-based cohort study. British Journal of Gynecology, 129 (2), 221–231.
- Egloff, C., et al., 2022. Pregnant women’s perceptions of the COVID-19 vaccine: a French survey. PLOS One, 17 (2), e0263512.
- Franchi, M., et al., 2020. Prevalence of SARS-CoV-2 infection in the obstetric population before the hospital admission. Minerva Ginecologica, 72 (6), 429–430.
- Stock, S.J., et al., 2022. SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland. Nature Medicine, 28 (3), 504–512.
- Vilca, L.M., et al., 2020. Barriers and facilitators regarding influenza and pertussis maternal vaccination uptake: a multi-center survey of pregnant women in Italy. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 247, 10–15.
- Vilca, L. M., et al., 2021. Differences between influenza and pertussis vaccination uptake in pregnancy: a multi-center survey study in Italy. European Journal of Public Health, 31 (6), 1150–1157.
- Vousden, N., et al., 2022. Management and implications of severe COVID-19 in pregnancy in the UK: data from the UK Obstetric Surveillance System National Cohort. Acta Obstetricia et Gynecologica Scandinavica, 101 (4), 461–470.